AtriCure Inc. (ATRC) Reaches $22.79 After 3.00% Up Move; Glen Burnie Bancorp Has 0.14 Sentiment

August 10, 2017 - By marketbeat

The stock of AtriCure Inc. (NASDAQ:ATRC) is a huge mover today! About 85,249 shares traded. AtriCure Inc. (NASDAQ:ATRC) has risen 53.35% since August 10, 2016 and is uptrending. It has outperformed by 36.65% the S&P500.The move comes after 8 months positive chart setup for the $782.48M company. It was reported on Aug, 10 by Barchart.com. We have $23.47 PT which if reached, will make NASDAQ:ATRC worth $23.47M more.

Glen Burnie Bancorp is the bank holding firm for The Bank of Glen Burnie , a commercial bank. The company has market cap of $29.30 million. The Bank is engaged in the commercial and retail banking business, including the acceptance of demand and time deposits, and the origination of loans to individuals, associations, partnerships and firms. It has a 25.76 P/E ratio. The Company’s real estate financing consists of residential first and second mortgage loans, home equity lines of credit and commercial mortgage loans.

Court Place Advisors Llc holds 0.1% of its portfolio in Glen Burnie Bancorp for 16,692 shares. Banc Funds Co Llc owns 70,849 shares or 0.03% of their US portfolio. Moreover, Alliancebernstein L.P. has 0% invested in the company for 115,183 shares. The North Carolina-based Bank Of America Corp De has invested 0% in the stock. Blackrock Fund Advisors, a California-based fund reported 598 shares.

Since January 1, 0001, it had 4 buys, and 0 insider sales for $45,862 activity.

It is down 12.05% since August 10, 2016 and is downtrending. It has underperformed by 28.75% the S&P500.

Since March 17, 2017, it had 0 insider buys, and 4 insider sales for $2.06 million activity. Seith Douglas J sold 58,112 shares worth $1.24M. Another trade for 10,000 shares valued at $214,400 was sold by Krell Elizabeth D. 20,000 shares were sold by LUX ANDREW L, worth $377,000. Hooven Michael D also sold $220,800 worth of AtriCure Inc. (NASDAQ:ATRC) on Friday, May 5.

Investors sentiment decreased to 1.31 in 2016 Q4. Its down 0.57, from 1.88 in 2016Q3. It worsened, as 9 investors sold AtriCure Inc. shares while 30 reduced holdings. 15 funds opened positions while 36 raised stakes. 25.67 million shares or 7.02% more from 23.98 million shares in 2016Q3 were reported. Moreover, Dafna Capital Mgmt Limited Liability Corp has 8.92% invested in AtriCure Inc. (NASDAQ:ATRC) for 518,946 shares. Blackrock Gru stated it has 0% of its portfolio in AtriCure Inc. (NASDAQ:ATRC). Consonance Mngmt L P owns 2.67 million shares for 5.73% of their portfolio. California State Teachers Retirement Systems has invested 0% in AtriCure Inc. (NASDAQ:ATRC). Parametric Associate Llc has invested 0% in AtriCure Inc. (NASDAQ:ATRC). 200,000 were reported by Bollard Limited Liability Corp. Pennsylvania-based Nationwide Fund Advsrs has invested 0% in AtriCure Inc. (NASDAQ:ATRC). Swiss State Bank, a Switzerland-based fund reported 51,100 shares. 110,394 are owned by Morgan Stanley. Rhumbline Advisers has 0% invested in AtriCure Inc. (NASDAQ:ATRC). Eventide Asset Mgmt Ltd Liability Company reported 180,000 shares or 0.23% of all its holdings. Blackrock Fund has invested 0% of its portfolio in AtriCure Inc. (NASDAQ:ATRC). Blackrock Inc owns 3,606 shares. Great West Life Assurance Can holds 0% or 2,154 shares. Credit Suisse Ag has 0% invested in AtriCure Inc. (NASDAQ:ATRC) for 69,251 shares.

Among 9 analysts covering Atricure Inc. (NASDAQ:ATRC), 8 have Buy rating, 1 Sell and 0 Hold. Therefore 89% are positive. Atricure Inc. had 20 analyst reports since July 30, 2015 according to SRatingsIntel. The stock has “Buy” rating by Needham on Wednesday, October 28. The firm has “Buy” rating given on Tuesday, October 6 by Canaccord Genuity. Needham maintained it with “Buy” rating and $30 target in Tuesday, October 6 report. Canaccord Genuity maintained the shares of ATRC in report on Monday, July 10 with “Buy” rating. The rating was maintained by Piper Jaffray with “Buy” on Friday, July 28. The rating was initiated by UBS on Tuesday, September 22 with “Sell”. The rating was initiated by BTIG Research on Friday, August 7 with “Buy”. Stifel Nicolaus maintained the stock with “Buy” rating in Friday, August 5 report. Piper Jaffray initiated AtriCure Inc. (NASDAQ:ATRC) on Tuesday, May 30 with “Buy” rating. The stock has “Sell” rating by UBS on Friday, August 5.

AtriCure, Inc. is an atrial fibrillation solutions company. The company has market cap of $782.48 million. The Firm develops, makes, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It currently has negative earnings. It has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com